Sirolimus for bronchial stenosis after lung transplantation

Sirolimus for bronchial stenosis after lung transplantation - Sirolimus for bronchial stenosis after lung transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028018

Enrollment

Registered

2017-06-30

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-lung transplant bronchial stenosis

Interventions

Administration of sirolimus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Post-lung transplant patients with bronchial stenosis who are treated with bronchial dilation or placing a stent every 3 months

Exclusion criteria

Exclusion criteria: Patients who have past history of bronchial dehiscence. Patients who received single lung transplantation for interstitial pneumonia. Patients with interstitial pneumonia. Patients with malignant lymphoma or malignant tumor or bronchial dehiscence. Patients who are pregnant. Patients who want to be pregnant.

Design outcomes

Primary

Measure	Time frame
Assessment of bronchial stenosis by chest CT scans or bronchoscopy	—

Countries

Japan

Contacts

Public ContactHisashi Oishi

Tohoku University Hospital Thoracic Surgery

hisashi.oishi.c7@tohoku.ac.jp022-717-8521

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026